1. Home
  2. ALDX vs CUB Comparison

ALDX vs CUB Comparison

Compare ALDX & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • CUB
  • Stock Information
  • Founded
  • ALDX 2004
  • CUB 2024
  • Country
  • ALDX United States
  • CUB United States
  • Employees
  • ALDX N/A
  • CUB N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • CUB
  • Sector
  • ALDX Health Care
  • CUB
  • Exchange
  • ALDX Nasdaq
  • CUB NYSE
  • Market Cap
  • ALDX 304.9M
  • CUB 310.7M
  • IPO Year
  • ALDX 2014
  • CUB 2024
  • Fundamental
  • Price
  • ALDX $6.71
  • CUB $10.24
  • Analyst Decision
  • ALDX Strong Buy
  • CUB
  • Analyst Count
  • ALDX 2
  • CUB 0
  • Target Price
  • ALDX $10.00
  • CUB N/A
  • AVG Volume (30 Days)
  • ALDX 666.8K
  • CUB 28.2K
  • Earning Date
  • ALDX 05-01-2025
  • CUB 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • CUB N/A
  • EPS Growth
  • ALDX N/A
  • CUB N/A
  • EPS
  • ALDX N/A
  • CUB N/A
  • Revenue
  • ALDX N/A
  • CUB N/A
  • Revenue This Year
  • ALDX N/A
  • CUB N/A
  • Revenue Next Year
  • ALDX N/A
  • CUB N/A
  • P/E Ratio
  • ALDX N/A
  • CUB N/A
  • Revenue Growth
  • ALDX N/A
  • CUB N/A
  • 52 Week Low
  • ALDX $2.75
  • CUB $9.96
  • 52 Week High
  • ALDX $7.20
  • CUB $10.55
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 57.30
  • CUB N/A
  • Support Level
  • ALDX $6.22
  • CUB N/A
  • Resistance Level
  • ALDX $7.20
  • CUB N/A
  • Average True Range (ATR)
  • ALDX 0.53
  • CUB 0.00
  • MACD
  • ALDX -0.01
  • CUB 0.00
  • Stochastic Oscillator
  • ALDX 79.59
  • CUB 0.00

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

Share on Social Networks: